Objective. National estimates of arthritis prevalence rely on a single survey question about doctor-diagnosed arthritis without using survey information on joint symptoms, even though some subjects with only the latter have been shown to have arthritis. The sensitivity of the current surveillance definition is only 53% and 69% in subjects ages 45-64 years and ages ≥65 years, respectively, resulting in misclassification of nearly one-half and one-third of subjects in those age groups. This study was undertaken to estimate arthritis prevalence based on an expansive surveillance definition that is adjusted for the measurement errors in the current definition.
Objective. National estimates of arthritis prevalence rely on a single survey question about doctor-diagnosed arthritis without using survey information on joint symptoms, even though some subjects with only the latter have been shown to have arthritis. The sensitivity of the current surveillance definition is only 53% and 69% in subjects ages 45-64 years and ages ≥65 years, respectively, resulting in misclassification of nearly one-half and one-third of subjects in those age groups. This study was undertaken to estimate arthritis prevalence based on an expansive surveillance definition that is adjusted for the measurement errors in the current definition.
Methods. Using the 2015 National Health Interview Survey, we developed a Bayesian multinomial latent class model for arthritis surveillance based on doctordiagnosed arthritis, joint symptoms, and whether symptom duration exceeded 3 months.
Results. Of 33,672 participants, 19.3% of men and 16.7% of women ages 18-64 years and 15.7% of men and 13.5% of women ages ≥65 years affirmed joint symptoms without doctor-diagnosed arthritis. The measurement error-adjusted prevalence of arthritis was 29.9% (95% Bayesian probability interval [95% PI] 23. 4-42. 3) in men ages 18-64 years, 31.2% (95% PI 25.8-44.1) in women ages 18-64 years, 55.8% (95% PI 49.9-70.4) in men ages ≥65 years, and 68.7% (95% PI 62.1-79.9) in women ages ≥65 years. Arthritis affected 91.2 million adults (of 247.7 million; 36.8%) in the US in 2015, which included 61.1 million persons between 18 and 64 years of age (of 199.9 million; 30.6%). Our arthritis prevalence estimate was 68% higher than the previously reported national estimate.
Conclusion. Arthritis prevalence in the US population has been substantially underestimated, especially among adults younger than 65 years of age.
Arthritis is a highly prevalent condition in the US and a leading cause of disability. The economic burden of arthritis is estimated to be at least $128 billion annually in the US (1) . Effective surveillance of arthritis on a national scale is challenging and requires a screening strategy that goes beyond recognizing symptoms reported in a clinical setting.
National surveillance efforts for arthritis rely on self-report surveys as a practical tool to estimate the burden of disease. The Centers for Disease Control and Prevention (CDC) routinely publishes estimates of the prevalence of arthritis in the US (2) (3) (4) . One source of data used for arthritis surveillance is the National Health Interview Survey (NHIS), administered by the US Census Bureau, which includes questions that are used to identify cases of arthritis. Although identifying subjects with arthritis from these health surveys is a reasonable method for national surveillance efforts, the accuracy of estimates depends on the validity of the surveillance definition used to identify cases of arthritis. The main item from the NHIS used to identify cases of arthritis has been a single question asking subjects if they ever had doctor-diagnosed arthritis.
In a validation study in which they actually verified clinical cases of arthritis, Sacks et al (5) documented the diagnostic sensitivity and specificity of arthritis-related survey questions. Survey validation has shown reassuring but imperfect accuracy. While a survey approach using a report of doctor-diagnosed arthritis had a higher sensitivity (68.8%) among those ages ≥65 years, the sensitivity of this surveillance definition was lower (52.5%) for persons ages 45-64 years. Such a low sensitivity, especially in a younger population, where almost half of true arthritis cases are missed, results in substantial misclassification and underestimation of prevalence and would have a detrimental effect on planning and needs assessment (3, 4) .
Subsequent studies that have relied on the assurance of the Sacks et al (5) validation study have produced a national estimate of the prevalence of arthritis or of doctor-diagnosed arthritis of 54.4 million adults (22.7%) in the US in 2015 (3, 4) . No data have been released that correct these estimates for the measurement errors caused by the imperfect sensitivity and specificity of surveillance definitions (3, 4, 6) . Further, this likely underestimation of arthritis prevalence, especially in subjects ages 45-64 years, has suggested that prevalence in this age group is low at a time when other studies noted a marked increase in the rates of knee and hip replacement in this age group (7) .
Strategies exist to increase the accuracy of surveillance criteria, such as combining the results of multiple individual diagnostic criteria. For example, one diagnostic criterion could be based on a self-reported diagnosis of arthritis from a health professional. Another diagnostic criterion could be self-reported symptoms that are consistent with arthritis. Questions about chronic joint symptoms are in fact included in the NHIS, and the Sacks et al (5) validation study reported that some subjects with chronic joint symptoms who did not report having doctordiagnosed arthritis had a clinical diagnosis of arthritis. Nonetheless, chronic joint symptoms have not been used in combination with doctor-diagnosed arthritis to derive national estimates of arthritis prevalence. While selfreported doctor-diagnosed arthritis has an acceptable specificity (i.e., 81.1%) for arthritis in adults ages ≥65 years (5), many persons younger than 65 years of age did not report receiving a diagnosis from a health professional despite reporting chronic joint symptoms.
In this study, we developed a Bayesian model to estimate the prevalence of arthritis among adults in the US in 2015, that is, an estimate adjusted for the measurement errors due to the imperfect accuracy of surveillance criteria based on both the report of chronic joint symptoms and doctor-diagnosed arthritis. We used the term "adjusted prevalence," in contrast to "unadjusted prevalence," for our measurement error-corrected prevalence estimates (8) (9) (10) (11) (12) (13) . We note that an adjusted prevalence estimate obtained using a survey is not equivalent to the exact number of rheumatologist-verified arthritis cases, even though the survey questions were actually validated against such cases, but we use the word "adjusted" to suggest that we are correcting estimates for the systematic underestimation of prevalence that occurs when surveillance instruments with imperfect sensitivity are used.
PATIENTS AND METHODS
Study setting and data. We obtained the most recent publicly available Sample Adult Core from the 2015 NHIS data release, which contains data for individuals ages 18 years and older. The NHIS, which is routinely used to derive national estimates of arthritis prevalence, is one of the most prominent population health surveys that covers the noninstitutionalized population in the US; it excludes those in long-term care facilities, active duty armed forces personnel, and US nationals living in a foreign country.
As noted in the study by Sacks et al (5) , the National Arthritis Data Workgroup suggested that "arthritis" be broadly defined as a condition with clinical significance that is either symptomatic or requires attention from a health professional for treatment. The purpose of the definition, which excluded injuries, was to have a practical method to estimate the burden and impact of arthritis. For example, a case of asymptomatic radiographic osteoarthritis resulting from a previous injury was not considered clinically significant, nor were asymptomatic Heberden's nodes.
In our study, identical to the definition used by the CDC, a case of doctor-diagnosed arthritis was defined as a positive response to the NHIS survey question, "Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?" In addition to doctor-diagnosed arthritis, the NHIS included a separate set of questions designed to identify those with chronic joint symptoms, defined as participants who gave a positive response to the question, "The next questions refer to your joints. Please do not include the back or neck. During the past 30 days, have you had any symptoms of pain, aching, or stiffness in or around a joint?" Moreover, if the person reported recent chronic joint symptoms, they were asked the follow-up question, "Did your joint symptoms first begin more than 3 months ago?" We developed surveillance criteria based on the 3 questions that were used to define doctor-diagnosed arthritis, chronic joint symptoms, and whether the duration of symptoms exceeded 3 months.
Surveillance criteria. We considered each of the 3 questions described in the previous section as a diagnostic test with imperfect accuracy for arthritis. The answer to the third question regarding the duration of symptoms was only available (i.e., positive or negative) if the person reported the existence of recent chronic joint symptoms. Therefore, the data consisted of frequencies corresponding to one of the 6 possible realizations of test outcomes (yes/yes/yes, yes/no/null, yes/yes/no, no/yes/yes, no/ no/null, or no/yes/no) for doctor-diagnosed arthritis, chronic joint symptoms, and duration of symptoms, respectively. The null value indicates that the value for the duration of symptoms was not available due to a negative response to the recent chronic joint symptoms criterion. We further stratified the results of the surveillance criteria into 4 subpopulations based on sex and the age groups 18-64 years and ≥65 years (Table 1) .
Model. We developed a Bayesian multinomial latent class model for the 6 realizations of test outcomes in the 4 subpopulations presented in Table 1 . Bayesian latent class models have previously been used in a variety of models for diagnostic test outcomes when a perfect reference standard is not available (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . Latent class models do not require the true disease status of each subject to be known (i.e., observed) in order to estimate prevalence and measures of diagnostic accuracy (12, 13) . The multinomial probabilities corresponding to the observed frequencies of surveillance criteria were defined as functions of true prevalence and the sensitivity and specificity of each criterion, as described by Branscum et al (9) and others (10) . For example, the probability of observing (yes/yes/yes) frequency is a product of the true arthritis prevalence and the sensitivities of the 3 criteria in the surveillance definition, which is the true-positive fraction plus the product of the prevalence of true nonarthritis (i.e., 1 À the prevalence of true arthritis) and the false-positive fraction (1 À the specificity of each criterion). All multinomial probabilities corresponding to observed frequencies are enumerated in the Supplementary Materials, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley. com/doi/10.1002/art.40355/abstract.
As shown in the validation study by Sacks et al (5) and in other studies (17, 22) , the sensitivity of a diagnostic test is often higher when it is applied to a population with higher prevalence (in this case, this would be true of older versus younger subjects). This occurs in part because there tends to be more severe disease in a high-prevalence population (17, 23) . In general, the diagnostic specificity, the probability of a negative outcome in a truly healthy (i.e., non-diseased) population, where the prevalence remains constant at 0, is less variable across nondiseased populations. To obtain a more robust estimate for arthritis prevalence (15, 17) , we allowed the sensitivity of the surveillance criteria to differ across the 4 subpopulations of men ages 18-64 years, women ages 18-64 years, men ages ≥65 years, and women ages ≥65 years. In an alternative parameterization for the purpose of sensitivity analysis, we assumed the sensitivity of the surveillance criteria to be the same among men and women, per estimates by Sacks et al (5) , but to be different only by age (i.e., higher sensitivity for the older population). The alternative parameterization involves fewer parameters to be estimated with the same degrees of freedom (i.e., 2 sensitivities for each criterion instead of 4 sensitivities for each criterion in the primary model). The number of parameters and degrees of freedom affect model identifiability, as discussed below.
The diagnostic specificity of criteria can be increased by serial interpretation of individual criteria results, that is, considering criteria positive when all individual components are positive. On the other hand, parallel interpretation of diagnostic criteria, that is, considering criteria positive when any individual component is positive, results in increased diagnostic sensitivity at the expense of reduced specificity. Similarly, sequential interpretation of criteria, where an individual criterion result is available only if another criterion is positive or negative, could result in improved sensitivity or specificity. Since subjects with symptoms such as pain are more likely to seek a health professional and receive a diagnosis of arthritis, we included conditional covariances, as described (24) , to account for the potential dependence between the outcomes for doctor-diagnosed arthritis and chronic joint symptoms. Conditional dependence affects the joint-testing sensitivity and specificity because the sensitivity (or specificity) of a test would not be independent of the outcome of another test (25) . A positive dependence between the sensitivities of the 2 tests occurs when the sensitivity of one test is lower among truly diseased subjects who have negative results on the other test and vice versa. Consequently, a positive or negative dependence between the sensitivities of 2 diagnostic criteria increases or decreases, respectively, serial joint-testing sensitivity. Similarly, a dependence between test specificities affects jointtesting accuracy (25) . Bayesian inference and priors. We used a Bayesian approach (26) to estimate the parameters of the multinomial latent class model for cross-classified outcomes of the arthritis surveillance criteria. In this approach, probability distributions are specified for model parameters, which consisted of the arthritis prevalences for the 4 subpopulations, the sensitivities and specificities of the surveillance criteria, and the conditional covariances between the outcomes of the doctor-diagnosed arthritis and chronic joint symptoms criteria. These probability distributions are referred to as priors and are elicited from past knowledge or expert opinion, or specified to be noninformative when every possible value of the parameter is defined to have an equal probability of occurring. The prior distributions are updated with the observed data to obtain posterior distributions for the parameters of the model using Markov chain Monte Carlo techniques (26) . The Monte Carlo-based posterior distributions are then summarized as the mean, median, or mode and the 2.5th and 97.5th percentiles of the Monte Carlo samples as Bayesian 95% probability intervals (95% PIs). For a description of prior elicitation and all the priors specified for the parameters of the multinomial model, see the Supplementary Materials, including Supplementary In latent class models, non-identifiability occurs when the model cannot guarantee a unique set of parameter estimates, often due to insufficient degrees of freedom (27) . Non-identifiability can be mitigated with proper informative priors or by putting constraints on priors in Bayesian analysis (15, 27, 28) . Hence, we ordered priors on prevalences and sensitivities in the subpopulations such that the prior distribution mean was higher in the older population than the younger population and higher in women than in men.
Bayesian analysis was performed using JAGS software (29) version 4.2.0 through rjags package (30) version 4-6 in R software (31) version 3.3.3. Beta priors were elicited using epiR package (32) version 0.9-79 in R. The program code for running Bayesian computations was adapted from the study by Branscum et al (9) . Table 1 presents the cross-classified outcomes of the arthritis surveillance criteria for 33,672 participants in the 2015 NHIS. In subjects ages 18-64 years, 19.3% of men (2,242 of 11,597) and 16.7% of women (2,294 of 13,697) responded "yes" to the question on chronic joint symptoms, regardless of whether symptom duration exceeded 3 months, but responded "no" to the question of whether they had ever received a diagnosis of arthritis from a doctor (Table 1) . Among those ages ≥65 years, 15.7% of men (545 of 3,474) and 13.5% of women (660 of 4,904) responded "yes" to the question on chronic joint symptoms, regardless of symptom duration, without a concurrent report of doctor-diagnosed arthritis ( Table 1) .
RESULTS
The proportion who responded "yes" to having doctor-diagnosed arthritis, with or without a concurrent report of chronic joint symptoms or symptom duration longer than 3 months if applicable, was 15.0% of men ages 18-64 years (1,740 of 11,597), 20.0% of women ages 18-64 years (2,734 of 13,697), 43.5% of men ages ≥65 years (1,511 of 3,474), and 55.1% of women ages ≥65 years (2,704 of 4,904) ( Table 1) .
Posterior probability estimates and the corresponding 95% PIs for the measurement error-adjusted prevalences in the 4 subpopulations stratified by age and sex are presented in Table 2 . The posterior median for the adjusted prevalence of arthritis based on the primary model was 29.9% (95% PI 23.4-42.3) in men ages 18-64 years, 31.2% (95% PI 25.8-44.1) in women ages 18-64 years, 55.8% (95% PI 49.9-70.4) in men ages ≥65 years, and 68.7% (95% PI 62.1-79.9) in women ages ≥65 years. The results of the sensitivity analysis that used identical values for sensitivity of the criteria in men and women suggested estimates similar to the results of the primary analysis (i.e., with overlapping 95% PIs) ( Table 2 ).
The accuracy of the surveillance criteria is provided in Table 3 . The results suggested that the doctordiagnosed arthritis criterion had very low sensitivity in subjects ages 18-64 years, and that the symptom duration criterion had the highest sensitivity across all age and sex strata, despite having the lowest specificity. Thus, a substantial fraction of the population with arthritis, who are between 18 and 64 years of age, but are misclassified as * Values are the posterior median probability (%) (95% probability interval). Adjusted prevalence, in contrast to unadjusted prevalence, is the estimate that is corrected for the measurement errors as a result of imperfect sensitivity and specificity of the surveillance criteria.
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healthy by the doctor-diagnosed arthritis criterion due to low sensitivity, are captured by the 2 remaining questions on joint pain, aching, or stiffness. Finally, the estimated number of adults with arthritis in the US, based on the 2015 National Population Projections provided by the US Census Bureau (33), was 91.2 million individuals (of the 247.7 million total projected population; 36.8%), which included 29.8 million men ages 18-64 years, 11.8 million men ages ≥65 years, 31.3 million women ages 18-64 years, and 18.3 million women ages ≥65 years.
DISCUSSION
Using NHIS data, we developed an arthritis surveillance definition by which to estimate the measurement error-adjusted prevalence of arthritis in the US, based on 3 criteria with imperfect accuracy, i.e., doctor-diagnosed arthritis, chronic joint symptoms, and symptom duration longer than 3 months. Our estimate suggested that 91.2 million adults in the US (36.8%) were affected by arthritis in 2015. Our results suggested that the adjusted prevalence of arthritis, doctor-diagnosed or otherwise, is substantially higher than a previously reported uncorrected estimate of the prevalence of doctor-diagnosed arthritis of 54.4 million adults in the US (22.7%) (4) and also higher than the estimate of the adjusted prevalence of doctor-diagnosed arthritis of 52.9 million adults (21.4%) (34) . Further, we estimated that 61.1 million adults between the ages of 18 and 64 years (of 199.9 million total adults ages 18-64 years; 30.6%) in the US had arthritis in 2015.
The higher prevalence that we report is due in large part to the previous underestimate of arthritis in adults ages 18-64 years. Recent reports have suggested a marked increase in total knee replacement utilization, especially in the population 45-64 years of age, that has outpaced the increasing rate of obesity in the same age group (7) . Another study demonstrated higher arthritis prevalence in more recent birth cohorts, compared to previous generations of the same age, partly due to changing patterns of obesity in relatively younger populations (35) . Individuals younger than 65 years of age may perceive arthritis as a condition affecting only the elderly and thus may visit a health professional less often or may ignore occasional joint symptoms. Moreover, arthritis may not be reported on electronic health records or insurance claims data if arthritis is not the primary reason for a referral to a health care provider. A previous study noted that of the total of 13.7% of adults (6,064 of 44,326) in the 2005 NHIS data who had chronic joint symptoms but * Values are the posterior median probability (%) (95% probability interval).
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no indication of doctor-diagnosed arthritis, 89.1% were younger than 65 years of age (36), compared to 79.0% (4,536 of 5,741) in our study population in 2015 (Table 1) . Previous studies that either supported (37, 38) or opposed (36) the addition of chronic joint symptoms to an arthritis surveillance definition, through creating a pseudogold standard based on other criteria such as functional or activity-limiting factors or any other indication of arthritis, are subject to the same flaws and limitations of relying on an imperfect surveillance definition. In contrast, our latent class analytic approach did not rely on the assumption of having a perfect reference standard (i.e., a gold standard) and did not require us to identify the true arthritis status of each individual in the population in order to estimate the measurement error-adjusted prevalence (8, 39) .
The question on doctor-diagnosed arthritis in the NHIS includes fibromyalgia among the conditions under the arthritis rubric. While fibromyalgia can cause joint pain and lead to a diagnosis by a health professional, it is not a form of arthritis. Consequently, inclusion of fibromyalgia resulted in an imperfect specificity for the doctor-diagnosed arthritis criterion, which affected the uncorrected estimates for the prevalence reported in previous studies (2-4); however, this inclusion did not affect our estimates for the adjusted prevalence because we had already corrected our estimate for the imperfect specificity of the doctor-diagnosed arthritis criterion. Conversely, absence of osteoarthritis, the most prevalent form of arthritis, from the NHIS question on doctor-diagnosed arthritis results in an imperfect sensitivity for the doctor-diagnosed arthritis criterion and subsequently affected uncorrected estimates for the prevalence in previous reports (2) (3) (4) .
In addition to problems with measurement errors, there are shortcomings in the reliance of the previously published (3,4) national estimates of arthritis prevalence on a single survey question regarding doctor-diagnosed arthritis. Implicit in the question on doctor-diagnosed arthritis, when the response is positive, is that the surveyed individual sought or had access to medical care from a health professional. However, a negative response to the doctor-diagnosed arthritis question could be the result of either lack of medical attention to joint symptoms or a truly negative diagnosis with regard to arthritis. Moreover, an individual who is diagnosed as having arthritis by a health professional may never be explicitly informed of the diagnosis.
The chronic joint symptoms question does not require pain on more than half of days and could represent mild or moderate joint pain. We note that the validation study by Sacks et al (5) reported the sensitivity and specificity of these questions for subjects who were ages 45-64 years. We generalized these estimates to those ages 18-64 years, and it is conceivable that our arthritis prevalence estimates for persons ages 18-44 years are off if these estimates of sensitivity and specificity are imprecise. However, our Bayesian approach mitigated this potential inaccuracy by specifying diffuse prior distributions that covered a wide range of sensitivity and specificity values, in contrast to a frequentist approach, in which these values are assumed to be fixed.
The NHIS has a complex survey sample design, and our approach did not use a weighting scheme to estimate prevalence. There are conceptually competing and fundamentally distinct approaches to making "inferences" from complex surveys, which include the classical design-based (randomization-based) approach that uses a weighting scheme, as described by Neyman (40) , and our model-based approach that relies on developing statistical models to infer population parameters. While weights are useful for "designing" a cost-effective survey sample, their use in inference after survey data are collected is debated in statistical literature because relying on weighting alone may fail to sufficiently account for other factors that influence the accuracy of estimation, such as misclassification. Weights are not attributes of the individuals or a particular disease under study, but are constructed as a product of probability calculations to correct for the perceived differences between a sample and a target population based on "design" variables such as age, sex, or location (41) .
There is a large body of statistical literature on the philosophical and fundamental differences between the design-based and the model-based approaches (see, for example, refs. [41] [42] [43] . Some argue that reliance on a general framework to calculate weights, which requires many arbitrary choices on weighting factor, pooling, or truncation of weights, does not provide much benefit over using a model-based approach to directly estimate parameters of interest, especially when auxiliary data are available (i.e., accuracy of survey questions) or when faced with biases unrelated to sampling weights, such as measurement error. While the federal agencies have historically produced statistical summaries using the design-based approach (44), the US Census Bureau recently formed a Research and Methodology Directorate to more effectively utilize model-based approaches for inference in official statistics by federal agencies (43) . Our approach was based on a model to adjust for the sensitivities and specificities of the test's performance in the 4 subpopulations identified by sex and age. We acknowledge that the inability to directly apply weighting in our model-based approach may have introduced inaccuracy with regard to the precision of our estimates (i.e., wider PIs for the probability of true population parameters), but the gain in 190 JAFARZADEH AND FELSON accuracy with regard to misclassification bias is so substantial that we believe it justifies our choice. The validity of our Bayesian inference relies on the correct specification and estimation of the underlying probability distributions that generated the observed frequencies of the NHIS questions' outcomes in the 4 subpopulations shown in Table 1 . Our modeling approach does not specify distinct priors on the diagnostic sensitivity and specificity of the NHIS questions across states, because the validation study by Sacks et al (5) did not provide evidence that the accuracy of NHIS questions varied by state. Therefore, regardless of the sampling unit from which an individual was selected, for example, Massachusetts versus New York, the probability of observing a specific realization of outcomes for the NHIS questions for an individual relies only on whether the individual has arthritis, and the sensitivities and specificities of the questions.
Our model-based approach provides several advantages over previous studies that did not correct for measurement errors (2) (3) (4) . In addition to directly applying the sensitivity and specificity of NHIS survey questions to our estimates, we allowed the correlation (i.e., conditional dependence) between responses to survey questions to be formally incorporated to get corrected estimates. Further, the Bayesian approach provided a coherent framework for model-based re-validation (i.e., that does not rely on a gold standard) of the findings of the Sacks et al (5) study, through updating the sensitivities and specificities of the survey questions from the validation study with the 2015 NHIS data, to obtain posterior probabilities (i.e., re-validated estimates), which we presented in Table 3 .
The underlying rheumatic diseases resulting in arthritis are diverse. While our inference was limited to aggregate-level population surveillance on the burden of arthritis, further studies are needed to evaluate potential changes in the specific causes of arthritis, especially among adults younger than 65 years of age. Arthritis causes enormous economic and public health implications. Direct health care costs and long-term indirect costs resulting from loss of productivity and disability attributable to arthritis need be revised to account for the corrected prevalence of arthritis affecting individuals at younger ages than previously perceived (1, 45) .
